An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia
Completed · Phase 3
Conditions studied: Hyponatremia
In brief
This study will investigate the application of a vasopressin antagonist in the treatment of hyponatremia most likely caused by inappropriate AVP secretion. The population studied will include patients with euvolemic or hypervolemic hyponatremia.
Key facts
- Study ID
- NCT00379847
- Run by
- Cumberland Pharmaceuticals
- People needed
- 251
- Starts
- 2004-02-01
- Expected to finish
- 2005-06-01
- Last updated by the study team
- 2014-05-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Serum sodium levels less than or equal 130mEq/L
- Euvolemic or Hypervolemic hyponatremia
You may not qualify if…
- Clinical evidence of volume depletion or dehydration
- Untreated severe hypothyroidism, hyperthyroidism, or adrenal insufficiency
- Uncontrolled brady-or tachyarrhythmias requiring pacemaker placement or treatment
Where it is running
- Study site — Tuscon, Arizona, United States
- Study site — Denver, Colorado, United States
- Study site — Washington D.C., District of Columbia, United States
- Study site — Augusta, Georgia, United States
- Study site — Petoskey, Michigan, United States
- Study site — Cincinnati, Ohio, United States
- Study site — Columbia, South Carolina, United States
- Study site — Afula, Israel
- Study site — Ashkelon, Israel
- Study site — Hadera, Israel
- 2 Sites — Haifa, Israel
- Study site — Holon, Israel
- 2 Sites — Jerusalem, Israel
- Study site — Nahariya, Israel
- Study site — Rehovot, Israel
- 2 Sites — Safed, Israel
- Study site — Tel Aviv, Israel
- Study site — Ẕerifin, Israel
- Study site — Amanzimototi, South Africa
- Study site — Bellville, South Africa
- Study site — Bloemfontein, South Africa
- 2 Sites — Durban, South Africa
- 4 Sites — Johannesburg, South Africa
- Study site — Krugersdorp, South Africa
- Study site — Lyttelton, South Africa
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.